|
UNK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.578000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.416800E-03 |
| Normal-vs-Stage2 |
3.998100E-02 |
| Normal-vs-Stage3 |
3.881500E-02 |
| Normal-vs-Stage4 |
5.443500E-02 |
| Stage1-vs-Stage2 |
8.656600E-01 |
| Stage1-vs-Stage3 |
8.021400E-01 |
| Stage1-vs-Stage4 |
8.742400E-01 |
| Stage2-vs-Stage3 |
7.362800E-01 |
| Stage2-vs-Stage4 |
9.682200E-01 |
| Stage3-vs-Stage4 |
7.500800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.756300E-04 |
| Normal-vs-AfricanAmerican |
1.419720E-02 |
| Normal-vs-Asian |
2.548600E-01 |
| Caucasian-vs-AfricanAmerican |
4.435400E-01 |
| Caucasian-vs-Asian |
6.960200E-01 |
| AfricanAmerican-vs-Asian |
8.807400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.212600E-04 |
| Normal-vs-Female |
4.403100E-04 |
| Male-vs-Female |
2.521000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.151800E-02 |
| Normal-vs-Extreme_Weight |
4.756900E-03 |
| Normal-vs-Obese |
3.737400E-03 |
| Normal-vs-Extreme_Obese |
3.265400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.082000E-01 |
| Normal_Weight-vs-Obese |
5.786400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.815400E-01 |
| Extreme_Weight-vs-Obese |
9.935600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.659400E-01 |
| Obese-vs-Extreme_Obese |
3.846800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.27600000000306E-05 |
| Normal-vs-Age(41-60Yrs) |
2.11610000000473E-06 |
| Normal-vs-Age(61-80Yrs) |
6.852300E-02 |
| Normal-vs-Age(81-100Yrs) |
9.415800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.092180E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.55488999999953E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.256390E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.007200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.402020E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.224200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.70560000001263E-06 |
| Normal-VS-Type2 PRCC |
8.118400E-01 |
| Normal-VS-KIRP CIMP |
1.038600E-01 |
| Normal-VS-Unclassified PRCC |
6.196400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.17150000003663E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.654800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.119800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.374800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.917000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.154400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.510000E-02 |
| Normal-vs-N1 |
3.950000E-02 |
| Normal-vs-N2 |
1.763160E-01 |
| N0-vs-N1 |
3.956200E-01 |
| N0-vs-N2 |
2.916200E-02 |
| N1-vs-N2 |
1.385750E-01 |
|
|
